# Marksans Pharma Ltd (MARKSANS)
> Exchange: NSE | Sector: Pharma | ISIN: INE750C01026

## About
Marksans Pharma Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 91.9%

## Valuation
P/E: 28.9
P/B: 4.9
EPS: ₹11.38
Book Value: ₹66.7
Dividend Yield: 0.27%

## Profitability
ROE: 15.2%

## Access
Current tier: anonymous
More history: Register free to see 10 more years.

## Data Freshness
Quote Updated: 2026-09-09T04:31:00.000Z
Price History Updated: 2026-09-10T20:56:18.758Z
Latest Price History Date: 2026-09-09
Technicals Updated: 2026-09-10T20:56:18.758Z
Quant Updated: 2026-09-10T20:56:18.758Z
Sentiment Updated: 2026-09-10T20:56:18.758Z
Financials Status: current
Financials Updated: 2026-09-12T13:27:33.201Z
Financials Last Attempt: 2026-09-12T13:27:33.201Z
Financials Provider Tried: screener.in+yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹3172 Cr
Operating Profit: ₹714 Cr (OPM 22%)
Net Profit: ₹521 Cr
Tax: ₹170 Cr

## Annual P&L History
TTM: Rev ₹3172Cr | PAT ₹521Cr | OPM 22%
FY26: Rev ₹2951Cr | PAT ₹420Cr | OPM 20%
FY25: Rev ₹2623Cr | PAT ₹383Cr | OPM 20%

## Balance Sheet (FY26)
Total Assets: ₹3856 Cr
Total Liabilities: ₹3856 Cr
Borrowings: ₹343 Cr
Cash: —

## Shareholding
Promoters: 43.87%
FIIs: 17.47%
DIIs: 6.19%
Public: 32.46%

---
Source: rupiya.io/stocks/marksans
Disclaimer: For research and education only. Not investment advice.